Since 2003, the Drugs for Neglected Diseases initiative has developed 12 treatments for 6 deadly diseases, saving millions of lives.
We innovate to save lives
We develop urgently needed treatments for neglected patients and work to ensure they’re affordable, available, and adapted to the communities who need them
We foster sustainable solutions
We work hand in hand with partners in low- and middle-income countries to power our progress and strengthen innovation ecosystems that put people’s needs first
We advocate for change
We speak out for policy change to enable more effective and equitable R&D and access to the fruits of science for all people in need, no matter their income or where they live
Better, shorter combination treatment for people with visceral leishmaniasis shown to be effective in Eastern Africa
New results from a study by DNDi and partners show that the combination treatment miltefosine and paromomycin is over 91% effective in treating visceral leishmaniasis in Eastern Africa. Children – who are the majority of visceral leishmaniasis patients – also responded well to this new treatment.
Read, watch, share
How we use our funding
We use the funds we receive to conduct life-saving research, build research networks, develop medicines, and advocate for neglected patients.
* 2021 financial year
Get our latest news, personal stories, research articles, and job opportunities.